| 000 | 02011cam a22003257a 4500 | ||
|---|---|---|---|
| 001 | vtls000310148 | ||
| 003 | UG-KaMUL | ||
| 005 | 20250613003512.0 | ||
| 020 | _a9780309138147 | ||
| 020 | _a0309138140 | ||
| 039 |
_y 201208161627 _z936 |
||
| 040 | _aUG-KaMUL | ||
| 060 |
_aQZ23 _b As741 2009 |
||
| 082 |
_a362.196/994 _2 22 |
||
| 245 |
_aAssessing and improving value in cancer care : _bworkshop summary / _cAdam Schickedanz, rapporteur ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academie s. |
||
| 260 |
_aWashington, D.C. : _bNational Academies Press, _c c2009. |
||
| 300 |
_axvi, 148 p. : _bill. ; _c 23 cm. |
||
| 500 | _a"On February 9 and 10, 2009, a public workshop titled Assessing and Improving Value in Cancer Care was presented to the Institute of Medici ne's (IOM's) National Cancer Policy Forum (the forum). This workshop wa s the result of the forum's discussions of value in oncology during mee tings held between March 2007 and October 2008."--P. 1. | ||
| 504 | _aIncludes bibliographical references. | ||
| 505 | _aIntroduction -- Opening remarks : what is value in cancer care and w hy is it important? -- Challenges to value in cancer care -- Clinician- patient communication and its influence on value -- Generating evidence about effectiveness and value -- Value and the oncology market -- Valu e in oncology practice : oncologist and health insurer perspectives -- Ethical issues and value in oncology -- Solutions for value in cancer c are -- Improving value in oncology practice : ways forward -- Toward a shared understanding of value. | ||
| 650 |
_aCancer _x Treatment _x Economic aspects _v Congresses. |
||
| 650 |
_aCancer _x Patients _x Medical care _v Congresses. |
||
| 650 |
_aNeoplasms _x therapy. |
||
| 650 |
_aNeoplasms _x economics _zUnited States. |
||
| 650 | _aPatients. | ||
| 700 | _aSchickedanz, Adam. | ||
| 710 | _aNational Cancer Policy Forum (U.S.) | ||
| 942 |
_2ddc _cBK |
||
| 999 |
_c552487 _d552487 |
||